S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.44 (-4.64%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.44 (-4.64%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.44 (-4.64%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.05 (-6.70%)
FB   191.71 (-2.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.05 (-1.77%)
MU   50.58 (-3.42%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.44 (-4.64%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Matinas BioPharmaMonash IVF GroupEnochian BiosciencesEmblemExicure
SymbolNYSEAMERICAN:MTNBASX:MVFOTCMKTS:ENOBCVE:EMCOTCMKTS:XCUR
Price Information
Current Price$1.03A$0.94$3.16N/A$2.00
52 Week RangeBuyN/AN/AN/ABuy
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/ABuy
Consensus Price Target$3.58N/AN/AN/A$7.33
% Upside from Price Target247.90% upsideN/AN/AN/A266.67% upside
Trade Information
Market Cap$193.66 million$220.46 million$170.42 million$248.31 million$177.15 million
BetaN/AN/AN/AN/AN/A
Average Volume3,086,098729,13351,976865,800334,476
Sales & Book Value
Annual RevenueN/A$151.86 millionN/A$5.71 millionN/A
Price / SalesN/A1.45N/A0.00N/A
CashflowN/AA$0.02 per shareN/AN/AN/A
Price / CashN/A48.10N/A4.08N/A
Book ValueN/AA$0.74 per shareN/A$0.67 per shareN/A
Price / BookN/A1.26N/A0.00N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AA$0.08N/A($0.19)N/A
Trailing P/E Ratio0.0011.990.00N/A0.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AA$0.06N/A$0.46N/A
Dividend YieldN/A6.42%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A76.92%N/AN/A N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A66.95%N/A30.01%N/A
Current RatioN/A0.80%N/A3.61%N/A
Quick RatioN/A0.44%N/A3.24%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees15588N/AN/A27
Shares Outstanding162.74 million235.79 million46.31 million132.08 million86.00 million
Next Earnings Date3/9/2020 (Confirmed)N/AN/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel